Skip to main content
Erschienen in: Annals of Hematology 9/2006

01.09.2006 | Original Article

Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin?

verfasst von: Nils Milman, Keld-Erik Byg, Thomas Bergholt, Lisbeth Eriksen, Anne-Mette Hvas

Erschienen in: Annals of Hematology | Ausgabe 9/2006

Einloggen, um Zugang zu erhalten

Abstract

This study aims to evaluate iron prophylaxis in pregnant women from the individual aspect, i.e. according to serum ferritin levels at the beginning of pregnancy, and to assess which dose of iron would be adequate to prevent iron deficiency (ID) and iron deficiency anaemia (IDA) during pregnancy and postpartum. A randomised, double-blind study comprising 301 healthy Danish pregnant women allocated into four groups taking ferrous iron (as fumarate) in doses of 20 mg (n=74), 40 mg (n=76), 60 mg (n=77) and 80 mg (n=75) from 18 weeks gestation (inclusion) to 8 weeks postpartum. Iron status markers [serum ferritin, serum soluble transferrin receptor (sTfR), haemoglobin] were recorded at 18, 32 and 39 weeks gestation and 8 weeks postpartum. Body iron was calculated using the serum sTfR/serum ferritin ratio. ID was defined by serum ferritin <12 μg/l in pregnancy and <15 μg/l postpartum; IDA as serum ferritin <12 μg/l and haemoglobin <5th percentile in iron-replete pregnant women. Women in the iron supplement groups were stratified according to serum ferritin levels at inclusion; 50.7% had ferritin ≤30 μg/l, 37.7% ferritin 30–70 μg/l and 11.6% ferritin >70 μg/l. At 32 weeks, women with ferritin ≤30 μg/l had an ID frequency of: 20-mg group 54.1%, 40 mg 29.7%, 60 mg 24.4%, 80 mg 20.6% (p<0.001); women with ferritin >30 μg/l had an ID frequency of: 20-mg group 20.0%, 40 mg 13.9%, 60 mg 5.7%, 80 mg 5.1% (p<0.001). Women with ferritin >70 μg/l had no ID. Postpartum, ID was found in 4.7% in 20-mg group, 2.9% in group 40 mg and 0% in group 60 and 80 mg. IDA: At 32 weeks, women with ferritin ≤30 μg/l had an IDA frequency of: 20-mg group 2.7%, 40 mg 2.7%, 60 and 80 mg 0%; none of the women with ferritin >30 μg/l displayed IDA. Body iron at 18 weeks was 10.4 mg/kg, similar in the four iron groups. Later in pregnancy body iron declined significantly, being lower the 20 mg group, and similar in the 40, 60 and 80-mg groups. Postpartum body iron rose to inclusion levels being 9.3 mg/kg in the 20-mg group and 10.5 mg/kg in the 40-, 60- and 80-mg groups. This study gives an estimate of iron dosage in individual iron prophylaxis adjusted to serum ferritin levels in early pregnancy. In the prevention of ID, we suggest 80–100 mg ferrous iron/day to women having ferritin ≤30 μg/l and 40 mg ferrous iron/day to women having ferritin 31–70 μg/l. In the prevention of IDA, we suggest 40 mg ferrous iron/day to women having ferritin ≤70 μg/l. Women with ferritin >70 μg/l have no need for iron supplement.
Literatur
1.
Zurück zum Zitat Bothwell TH (200) Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 72(suppl 1):257S–264S Bothwell TH (200) Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 72(suppl 1):257S–264S
2.
Zurück zum Zitat Milman N, Bergholt T, Byg K-E, Eriksen L, Graudal N (1999) Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand 78:749–757PubMedCrossRef Milman N, Bergholt T, Byg K-E, Eriksen L, Graudal N (1999) Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand 78:749–757PubMedCrossRef
3.
Zurück zum Zitat van den Broek NR, Letsky EA, White SA, Shenkin A (1998) Iron status in pregnant women: which measurements are valid? Br J Haematol 103:817–824PubMedCrossRef van den Broek NR, Letsky EA, White SA, Shenkin A (1998) Iron status in pregnant women: which measurements are valid? Br J Haematol 103:817–824PubMedCrossRef
4.
Zurück zum Zitat Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRef Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRef
5.
Zurück zum Zitat Nordic Council of Ministers (2004) Nordic nutrition recommendations 2004, 4th edn. Nord, Copenhagen, pp 364–366 Nordic Council of Ministers (2004) Nordic nutrition recommendations 2004, 4th edn. Nord, Copenhagen, pp 364–366
6.
Zurück zum Zitat US Preventive Services Task Force (1993) Routine iron supplementation during pregnancy. Policy statement. Review article. JAMA 270:2846–2854CrossRef US Preventive Services Task Force (1993) Routine iron supplementation during pregnancy. Policy statement. Review article. JAMA 270:2846–2854CrossRef
7.
Zurück zum Zitat Milman N, Agger OA, Nielsen OJ (1991) Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo-controlled study in 207 Danish women. Dan Med Bull 38:471–476PubMed Milman N, Agger OA, Nielsen OJ (1991) Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo-controlled study in 207 Danish women. Dan Med Bull 38:471–476PubMed
8.
Zurück zum Zitat Milman N, Byg K-E, Graudal N, Agger AO (2000) Reference values for hemoglobin and erythrocyte indices during normal pregnancy in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand 78:89–98CrossRef Milman N, Byg K-E, Graudal N, Agger AO (2000) Reference values for hemoglobin and erythrocyte indices during normal pregnancy in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand 78:89–98CrossRef
9.
Zurück zum Zitat Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years. Influence of menstruation, method of contraception, and iron supplementation. Ann Hematol 76:13–19CrossRef Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years. Influence of menstruation, method of contraception, and iron supplementation. Ann Hematol 76:13–19CrossRef
10.
Zurück zum Zitat Institute of Medicine, Food and Nutrition Board (1993) Iron deficiency anemia: recommended guidelines for the prevention, detection, and management among US children and women of childbearing age. National Academy, Washington, District of Columbia Institute of Medicine, Food and Nutrition Board (1993) Iron deficiency anemia: recommended guidelines for the prevention, detection, and management among US children and women of childbearing age. National Academy, Washington, District of Columbia
11.
Zurück zum Zitat Haram K, Hervig T, Ulvik R (1997) New aspects on preventive iron supplementation in normal pregnancy. Tidsskr Nor Laegeforen 117:966–969PubMed Haram K, Hervig T, Ulvik R (1997) New aspects on preventive iron supplementation in normal pregnancy. Tidsskr Nor Laegeforen 117:966–969PubMed
12.
Zurück zum Zitat Milman N, Bergholt T, Eriksen, L, Byg K-E, Graudal N, Pedersen P, Hertz J (2005) Iron prophylaxis during pregnancy—how much iron is needed? A randomised dose response study of 20 to 80 mg ferrous iron daily to pregnant women. Acta Obstet Gynecol Scand 84:238–247PubMedCrossRef Milman N, Bergholt T, Eriksen, L, Byg K-E, Graudal N, Pedersen P, Hertz J (2005) Iron prophylaxis during pregnancy—how much iron is needed? A randomised dose response study of 20 to 80 mg ferrous iron daily to pregnant women. Acta Obstet Gynecol Scand 84:238–247PubMedCrossRef
13.
Zurück zum Zitat Cook JD, Flowers CH, Skikne BS (2003) The quantitative assessment of body iron. Blood 101:3359–3364PubMedCrossRef Cook JD, Flowers CH, Skikne BS (2003) The quantitative assessment of body iron. Blood 101:3359–3364PubMedCrossRef
14.
Zurück zum Zitat Milman N, Juul-Jørgensen B, Bentzon MW (1997) Calibration of the Abbott AxSYM Ferritin kit using the WHO Human Liver Ferritin International Standard 80/602. Clin Chem 35:631–632 Milman N, Juul-Jørgensen B, Bentzon MW (1997) Calibration of the Abbott AxSYM Ferritin kit using the WHO Human Liver Ferritin International Standard 80/602. Clin Chem 35:631–632
15.
Zurück zum Zitat Cook JD, Skikne B (1989) Iron deficiency: definition and diagnosis. J Intern Med 226:349–355PubMed Cook JD, Skikne B (1989) Iron deficiency: definition and diagnosis. J Intern Med 226:349–355PubMed
16.
Zurück zum Zitat Worwood M (1994) Laboratory determination of iron status. In Brock, JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Saunders, London, pp 449–476 Worwood M (1994) Laboratory determination of iron status. In Brock, JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Saunders, London, pp 449–476
17.
Zurück zum Zitat Milman N, Pedersen NS, Visfeldt J (1983) Serum ferritin in healthy Danes: relation to marrow haemosiderin iron stores. Dan Med Bull 30:115–120PubMed Milman N, Pedersen NS, Visfeldt J (1983) Serum ferritin in healthy Danes: relation to marrow haemosiderin iron stores. Dan Med Bull 30:115–120PubMed
18.
Zurück zum Zitat Wright RO, Shannon MW, Wright RJ, Hu H (2000) Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am J Public Health 89:1049–1053CrossRef Wright RO, Shannon MW, Wright RJ, Hu H (2000) Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am J Public Health 89:1049–1053CrossRef
19.
Zurück zum Zitat Akesson A, Berglund M, Schutz A, Bjellerup P, Bremme K, Vahter M (2002) Cadmium exposure in pregnancy and lactation in relation to iron status. Am J Public Health 92:284–287PubMed Akesson A, Berglund M, Schutz A, Bjellerup P, Bremme K, Vahter M (2002) Cadmium exposure in pregnancy and lactation in relation to iron status. Am J Public Health 92:284–287PubMed
20.
Zurück zum Zitat Skikne B, Baynes RD (1994) Iron absorption. In Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. Saunders, London, pp 151–187 Skikne B, Baynes RD (1994) Iron absorption. In Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. Saunders, London, pp 151–187
21.
Zurück zum Zitat Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L (1991) Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54:152–156PubMed Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L (1991) Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54:152–156PubMed
22.
Zurück zum Zitat Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT (1999) Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 69:250–255PubMed Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT (1999) Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 69:250–255PubMed
23.
Zurück zum Zitat Taylor DJ, Mallen C, McDougall N, Lind T (1982) Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol 89:1011–1017PubMed Taylor DJ, Mallen C, McDougall N, Lind T (1982) Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol 89:1011–1017PubMed
24.
Zurück zum Zitat Galan P, Wainer R, De Benaze C, Hercberg S (1990) Prevention de l’anemie ferriprive au cours de la grossesse: effet de la supplementation precoce en fer. In: Hercberg S, Galan P, Dupin H (eds) Recent knowledge on iron and folate deficiencies in the World. INSERM, Paris, 615–621 Galan P, Wainer R, De Benaze C, Hercberg S (1990) Prevention de l’anemie ferriprive au cours de la grossesse: effet de la supplementation precoce en fer. In: Hercberg S, Galan P, Dupin H (eds) Recent knowledge on iron and folate deficiencies in the World. INSERM, Paris, 615–621
25.
Zurück zum Zitat Eskeland E, Malterud K, Ulvik RJ, Hunskaar S (1997) Iron supplementation in pregnancy: is less enough? Acta Obstet Gynecol Scand 76:822–828PubMedCrossRef Eskeland E, Malterud K, Ulvik RJ, Hunskaar S (1997) Iron supplementation in pregnancy: is less enough? Acta Obstet Gynecol Scand 76:822–828PubMedCrossRef
26.
Zurück zum Zitat Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM (2003) Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 78:145–153PubMed Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM (2003) Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 78:145–153PubMed
27.
Zurück zum Zitat Byg K-E, Milman N, Agger AO (2000) Correlations between iron status markers during normal pregnancy in women with and without iron supplementation. Hematology 4:529–539PubMed Byg K-E, Milman N, Agger AO (2000) Correlations between iron status markers during normal pregnancy in women with and without iron supplementation. Hematology 4:529–539PubMed
28.
Zurück zum Zitat Thompson WG (1988) Comparison of tests for diagnosis of iron depletion in pregnancy. Am J Obstet Gynecol 5:1132–1134 Thompson WG (1988) Comparison of tests for diagnosis of iron depletion in pregnancy. Am J Obstet Gynecol 5:1132–1134
29.
Zurück zum Zitat van den Broek NR, Letsky EA, White SA, Shenkin A (1998) Iron status in pregnant women: which measurements are valid? Br J Haematol 103:817–824PubMedCrossRef van den Broek NR, Letsky EA, White SA, Shenkin A (1998) Iron status in pregnant women: which measurements are valid? Br J Haematol 103:817–824PubMedCrossRef
30.
Zurück zum Zitat Carriage MT, Skikne S, Finley B, Cutler B, Cook JD (1991) Serum transferrin receptor for the detection of iron deficiency. Am J Clin Nutr 54:107–181 Carriage MT, Skikne S, Finley B, Cutler B, Cook JD (1991) Serum transferrin receptor for the detection of iron deficiency. Am J Clin Nutr 54:107–181
31.
Zurück zum Zitat Akesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (1998) Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr 68:1241–1246PubMed Akesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (1998) Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr 68:1241–1246PubMed
32.
Zurück zum Zitat Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 76:13–19CrossRef Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 76:13–19CrossRef
33.
Zurück zum Zitat Danish National Board of Health (1992) Recommendations about iron supplementation during pregnancy. Ugeskr Laeger 154:3445 Danish National Board of Health (1992) Recommendations about iron supplementation during pregnancy. Ugeskr Laeger 154:3445
34.
Zurück zum Zitat Milman N (2006) Iron and pregnancy—a delicate balance. Ann Hematol May 12 (Epub ahead of print) Milman N (2006) Iron and pregnancy—a delicate balance. Ann Hematol May 12 (Epub ahead of print)
35.
Zurück zum Zitat Nokes C, van den Bosch C, Bundy D (1998) The effects of iron deficiency and anemia on mental and motor performance, educational achievement, and behavior in children. A report of the INACG. International Life Sciences Institute, Washington, DC Nokes C, van den Bosch C, Bundy D (1998) The effects of iron deficiency and anemia on mental and motor performance, educational achievement, and behavior in children. A report of the INACG. International Life Sciences Institute, Washington, DC
36.
37.
Zurück zum Zitat Grantham-McGregor S, Ani C (2001) A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 131:649S–668SPubMed Grantham-McGregor S, Ani C (2001) A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 131:649S–668SPubMed
38.
Zurück zum Zitat Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the haemochromatosis (HFE) gene in 2501 ethnic Danes. Ann Hematol 83:654–657PubMedCrossRef Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the haemochromatosis (HFE) gene in 2501 ethnic Danes. Ann Hematol 83:654–657PubMedCrossRef
Metadaten
Titel
Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin?
verfasst von
Nils Milman
Keld-Erik Byg
Thomas Bergholt
Lisbeth Eriksen
Anne-Mette Hvas
Publikationsdatum
01.09.2006
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 9/2006
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0141-1

Weitere Artikel der Ausgabe 9/2006

Annals of Hematology 9/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.